Cigarette Smoke or Motor Vehicle Exhaust Exposure Induces PD-L1 Upregulation in Lung Epithelial Cells in COPD Model Rats

References

• Tockman MS, Anthonisen NR, Wright EC, et al. Airways obstruction and the risk for lung cancer. Ann Intern Med. 1987;106(4):512–518. DOI:10.7326/0003-4819-106-4-512
   PubMed Web of Science ®Google Scholar
• Young RP, Hopkins RJ, Christmas T, et al. COPD prevalence is increased in lung cancer, independent of age, sex and smoking history. Eur Respir J. 2009;34(2):380–386. DOI:10.1183/09031936.00144208
   PubMed Web of Science ®Google Scholar
• Fajersztajn L, Veras M, Barrozo LV, et al. Air pollution: a potentially modifiable risk factor for lung cancer. Nat Rev Cancer. 2013;13(9):674–678.
   PubMed Web of Science ®Google Scholar
• Hecht SS. Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst. 1999;91(14):1194–1210. DOI:10.1093/jnci/91.14.1194
   PubMedGoogle Scholar
• Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China pulmonary health [CPH] study): a national cross-sectional study. Lancet. 2018;391(10131):1706–1717. DOI:10.1016/S0140-6736(18)30841-9
   PubMed Web of Science ®Google Scholar
• Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer. 2012;12(4):252–264.
   PubMed Web of Science ®Google Scholar
• Lee MH, Yanagawa J, Tran L, et al. FRA1 contributes to MEK-ERK pathway-dependent PD-L1 upregulation by KRAS mutation in premalignant human bronchial epithelial cells. Am J Transl Res. 2020;12(2):409–427.
   PubMed Web of Science ®Google Scholar
• Jia M, Feng W, Kang S, et al. Evaluation of the efficacy and safety of anti-PD-1 and anti-PD-L1 antibody in the treatment of non-small cell lung cancer (NSCLC): a Meta-analysis. J Thorac Dis. 2015;7(3):455–461.
   PubMed Web of Science ®Google Scholar
• Mark NM, Kargl J, Busch SE, et al. Chronic obstructive pulmonary disease alters immune cell composition and immune checkpoint inhibitor efficacy in Non-Small cell lung cancer. Am J Respir Crit Care Med. 2018;197(3):325–336. DOI:10.1164/rccm.201704-0795OC
   PubMed Web of Science ®Google Scholar
• Kang X, Li P, Zhang C, et al. The TLR4/ERK/PDL1 axis may contribute to NSCLC initiation. Int J Oncol. 2020;57(2):456–465.
   PubMed Web of Science ®Google Scholar
• Liu CH, Chen Z, Chen K, et al. Lipopolysaccharide-mediated chronic inflammation promotes tobacco carcinogen-induced lung cancer and determines the efficacy of immunotherapy. Cancer Res. 2020;81:144–157. DOI:10.1158/0008-5472.CAN-20-1994
   PubMed Web of Science ®Google Scholar
• Shu J, Lu W, Yang K, et al. Establishment and evaluation of chronic obstructive pulmonary disease model by chronic exposure to motor vehicle exhaust combined with lipopolysaccharide instillation. Exp Physiol. 2018;103(11):1532–1542.
   PubMed Web of Science ®Google Scholar
• Li D, Wang J, Sun D, et al. Tanshinone IIA sulfonate protects against cigarette smoke-induced COPD and down-regulation of CFTR in mice. Sci Rep. 2018;8(1):376.
   PubMedGoogle Scholar
• Wang GZ, Zhang L, Zhao XC, et al. The aryl hydrocarbon receptor mediates tobacco-induced PD-L1 expression and is associated with response to immunotherapy. Nat Commun. 2019;10(1):1125.
   PubMedGoogle Scholar
• Chen S, Li D, Zhang H, et al. The development of a cell-based model for the assessment of carcinogenic potential upon long-term PM2.5 exposure. Environ Int. 2019;131:104943. DOI:10.1016/j.envint.2019.104943
   PubMed Web of Science ®Google Scholar
• Xu Z, Wu H, Zhang H, et al. Interleukins 6/8 and cyclooxygenase-2 release and expressions are regulated by oxidative stress-JAK2/STAT3 signaling pathway in human bronchial epithelial cells exposed to particulate matter < = 2.5 mum. J Appl Toxicol. 2020;40(9):1210–1218.
   PubMed Web of Science ®Google Scholar
• Narayanapillai SC, Han YH, Song JM, et al. Modulation of the PD-1/PD-L1 immune checkpoint axis during inflammation-associated lung tumorigenesis. Carcinogenesis. 2020;41(11):1518–1528.
   PubMed Web of Science ®Google Scholar
• Shao MX, Ueki IF, Nadel JA. Tumor necrosis factor alpha-converting enzyme mediates MUC5AC mucin expression in cultured human airway epithelial cells. Proc Natl Acad Sci USA. 2003;100(20):11618–11623. DOI:10.1073/pnas.1534804100
   PubMed Web of Science ®Google Scholar
• Aldarouish M, Su X, Qiao J, et al. Immunomodulatory effects of chemotherapy on blood lymphocytes and survival of patients with advanced non-small cell lung cancer. Int J Immunopathol Pharmacol. 2019;33:2058738419839592.
   Web of Science ®Google Scholar
• Kim GJ, Lee JH, Park WJ, et al. The prognostic value of measuring PD-L1 mRNA expression levels in surgically resected Non-Small cell lung cancer. Ann Clin Lab Sci. 2019;49(3):317–323.
   PubMed Web of Science ®Google Scholar
• Chen N, Fang W, Lin Z, et al. KRAS mutation-induced upregulation of PD-L1 mediates immune escape in human lung adenocarcinoma. Cancer Immunol Immunother. 2017;66(9):1175–1187.
   PubMed Web of Science ®Google Scholar
• McKendry RT, Spalluto CM, Burke H, et al. Dysregulation of antiviral function of CD8(+) T cells in the chronic obstructive pulmonary disease lung. Role of the PD-1-PD-L1 axis. Am J Respir Crit Care Med. 2016;193(6):642–651.
   PubMed Web of Science ®Google Scholar
• Shima T, Shimoda M, Shigenobu T, et al. Infiltration of tumor-associated macrophages is involved in tumor programmed death-ligand 1 expression in early lung adenocarcinoma. Cancer Sci. 2020;111(2):727–738.
   PubMed Web of Science ®Google Scholar
• Kauffmann-Guerrero D, Kahnert K, Kiefl R, et al. Systemic inflammation and pro-inflammatory cytokine profile predict response to checkpoint inhibitor treatment in NSCLC: a prospective study. Sci Rep. 2021;11(1):10919.
   PubMed Web of Science ®Google Scholar
• Zhao S, Gao J, Li J, et al. PD-L1 regulates inflammation in LPS-Induced lung epithelial cells and vascular endothelial cells by interacting with the HIF-1α Signaling Pathway. Inflammation. 2021;44(5):1969–1981.
   PubMed Web of Science ®Google Scholar
• Guan R, Wang J, Li D, et al. Hydrogen sulfide inhibits cigarette smoke-induced inflammation and injury in alveolar epithelial cells by suppressing PHD2/HIF-1α/MAPK signaling pathway. Int Immunopharmacol. 2020;81:105979. DOI:10.1016/j.intimp.2019.105979
   PubMed Web of Science ®Google Scholar
• Park EJ, Park YJ, Lee SJ, et al. Whole cigarette smoke condensates induce ferroptosis in human bronchial epithelial cells. Toxicol Lett. 2019;303:55–66. DOI:10.1016/j.toxlet.2018.12.007
   PubMed Web of Science ®Google Scholar
• Blanchet S, Ramgolam K, Baulig A, et al. Fine particulate matter induces amphiregulin secretion by bronchial epithelial cells. Am J Respir Cell Mol Biol. 2004;30(4):421–427. DOI:10.1165/rcmb.2003-0281RC
   PubMed Web of Science ®Google Scholar
• Wu J, Shi Y, Asweto CO, et al. Fine particle matters induce DNA damage and G2/M cell cycle arrest in human bronchial epithelial BEAS-2B cells. Environ Sci Pollut Res Int. 2017;24(32):25071–25081.
   PubMed Web of Science ®Google Scholar
• Miller A, Brooks GD, McLeod L, et al. Differential involvement of gp130 signalling pathways in modulating tobacco carcinogen-induced lung tumourigenesis. Oncogene. 2015;34(12):1510–1519.
   PubMed Web of Science ®Google Scholar
• Zhang X, Zeng Y, Qu Q, et al. PD-L1 induced by IFN-gamma from tumor-associated macrophages via the JAK/STAT3 and PI3K/AKT signaling pathways promoted progression of lung cancer. Int J Clin Oncol. 2017;22(6):1026–1033.
   PubMed Web of Science ®Google Scholar
• Li YM, Yu JM, Liu ZY, et al. Programmed death ligand 1 indicates pre-existing adaptive immune response by tumor-infiltrating CD8(+) T cells in non-small cell lung cancer. Int J Mol Sci. 2019:20:20.
   Web of Science ®Google Scholar
• Seki N, Kan OK, Matsumoto K, et al. Interleukin-22 attenuates double-stranded RNA-induced upregulation of PD-L1 in airway epithelial cells via a STAT3-dependent mechanism. Biochem Biophys Res Commun. 2017;494(1–2):242–248. DOI:10.1016/j.bbrc.2017.10.045
   PubMed Web of Science ®Google Scholar